Perrigo Company
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 37.27 |
| 52 Week High | 43.08 |
| 52 Week Low | 21.42 |
| Avg. Daily Vol. (Mil) | 1.07 |
| Beta (3 year) | 0.31 |
| Share Related Items | |
| Mkt Cap (Mil) | 3,472.33 |
| Shares Out (Mil) | 93.17 |
| Float (Mil) | 79.49 |
| Dividend Information | |
| Yield % | 0.50 |
| Annual Dividend | 0.20 |
| Payout Ratio | 14.00 |
| Financial Strength | |
| Quick Ratio | 1.40 |
| Current Ratio | 2.40 |
| LT Debt/ Equity | 0.96 |
| Total Debt / Equity | 0.98 |
| Valuation Ratios | |
| Price Earnings | 26.10 |
| Price/Sales | 1.91 |
| Price/Book | 3.72 |
| Price/Cash Flow | 16.90 |
| Per Share Data | |
| Earnings | 1.43 |
| Sales | 19.56 |
| Book Value | 10.02 |
| Cash Flow | 2.20 |
| Business Summary | |
|---|---|
| The Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. | |
| General Information | |
| 515 Eastern Avenue
Allegan, MI 49010 |
|
| www.perrigo.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 6200 | |
| CEO: Joseph C. Papa | |
| Short Interest | |
| Current Month (Mil) | 4.74 |
| Previous Month (Mil) | 5.54 |
| Short Interest Ratio (Days) | 4.90 |
| Management Effectiveness | |
| Return on Equity | 14.50 |
| Return on Assets | 5.30 |
| Return on Investments | 7.40 |
| Profitability | |
| Gross Margin | 34.00 |
| EBIT Margin | 10.80 |
| Profit Margin | 7.50 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas